Want to see SG:8K7 full AI Analyst Report?
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.11
Previous CloseN/A
Volume145.10K
Average Volume (3M)151.48K
Market Cap
S$48.03M
Enterprise ValueS$59.15
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)22.6
Beta0.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.62%
Share Statistics
EPS (TTM)N/A
Shares Outstanding623,825,800
10 Day Avg. Volume38,170
30 Day Avg. Volume151,483
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)0.28
Price to Sales (P/S)0.32
P/FCF Ratio3.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Profitability RecoveryThe return to profitability and higher gross margin indicate improved pricing, product economics, or cost control. Sustaining these gains would strengthen the core PPE business and provide a more durable base for future cash generation.
Positive Free Cash FlowPositive operating and free cash flow improves financial flexibility, allowing the company to fund operations and investment with less reliance on external capital. The reversal from prior negative periods is a meaningful recovery in cash-generation capacity.
Moderate LeverageModerate leverage limits balance-sheet strain and preserves flexibility if the PPE market remains uneven. A sizable equity base can help the company absorb volatility while supporting continued operations and selective investment in its healthcare products business.
Bears Say
Thin Profitability And Low ReturnsAlthough earnings recovered, thin margins and very low ROE show that the business is not yet converting revenue or equity into strong returns. Limited profitability leaves less protection against pricing pressure, input-cost increases, or weaker demand.
Volatile Demand RecoveryRevenue remains below prior peaks, indicating that post-pandemic demand normalization has not been fully overcome. This history makes the recovery less predictable and suggests that future growth may depend on rebuilding volumes across healthcare, institutional, and industrial customers.
Cash-Flow Execution RiskThe recent cash-flow improvement is encouraging, but several prior years of negative cash generation demonstrate execution risk through the cycle. Cash conversion below net income also means reported profitability may not consistently translate into usable funds.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.07 and its highest was S$0.11 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$48.03M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
Currently, no data Available
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of 1.62%. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex Examination Gloves, Nitrile Examination Gloves, and a category for Other Ancillary Products. The company's offerings include both latex examination gloves, available in single and double chlorinated polymer-coated varieties, as well as nitrile examination gloves. Additionally, it supplies a range of supplementary items like surgical gloves, vinyl and cleanroom disposable gloves, face masks, various other medical disposables, and protective shoe covers. The firm also extends its expertise through business and management consultancy services. Its products serve diverse sectors such as healthcare, food and beverage, industrial and high-technology manufacturing, automotive, research and development, and the beauty industry. Operating under its "Unigloves" brand name, the corporation reaches customers across Malaysia, Europe, North America, South America, Africa, and the broader Asian market.
Technical Analysis
Hyphens Pharma International Ltd.
―
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―